|
Avecia is to sell Avecia Inkjet, the Manchester-based supplier of ink dyes with 340 staff, to Fuji Photo of Japan for £150m. 28-Dec-2005 Avecia is to sell its pharmaceutical synthesis business to Nicholas Piramal India for £9.5m, involving the transfer of 350 staff at sites in Huddersfield, Grangemouth, Billingham and the US. 28-Oct-2005 Avecia is to close its biotechnology laboratory at Grangemouth this summer, with the loss of 95 jobs. 11-Apr-2005 Avecia is to sell its NeoResins coatings and inks business, which has 635 staff at five sites worldwide, to DSM of the Netherlands for £355m. 15-Dec-2004 Intertek is to acquire Avecia's analytical sciences laboratory in Manchester, with the transfer of 53 staff, having won a contract to provide chemical testing services to Avecia. 17-May-2004 Avecia is to sell its biocides business, which has 290 staff at sites in Huddersfield, Grangemouth, Manchester and the US, to Arch Chemicals of the US for £118m. 11-Mar-2004 Avecia has agreed to sell its Metal Extraction Products and Intermediates & Stabilizers operations in the US to Cytec for about £60m, which will involve the transfer of 200 staff. 01-Jul-2003 Avecia is seeking planning permission for the £1.9m extension of its pharmaceutical laboratory facilities in Billingham. 27-Jun-2002 Avecia has confirmed plans to build a £70m biological medicines plant in Billingham by 2005, creating 300 jobs at what will be the world's largest pharmaceutical microbial fermentation facility. 28-Feb-2002 Avecia is seeking permission to build a new bio-pharmaceutical manufacturing facility at its site in Billingham, with the creation of about 300 jobs. 07-Jan-2002 Avecia is planning to sell Stahl, the Dutch supplier of leather finishing chemicals with 1,500 staff in 28 countries, to a management buy-out for £232m. 28-Dec-2001 Avecia is considering plans to close its pigments facility in Grangemouth, which would involve the redeployment of 130 workers. 02-Jun-2000
|